Moderna (MRNA) Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Search jobs 07-May-2021 Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses
New Switzerland agreement and option is in additional to earlier agreements for 13.5 million doses
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a new supply agreement with the Swiss Federal Government for 7 million doses of booster vaccine in 2022, with an additional option for another 7 million doses for delivery during the second half of 2022 or first quarter of 2023. Purchase under this agreement is subject to regulatory approval of the booster vaccine candidate. Today’s announcement follows two earlier agreements between Switzerland and Moderna to supply a total of 13.5 million doses of the COVID-19 Vaccine Moderna. Swissmedic, the Swiss Agency for Therapeutic Products, aut
Moderna COVID booster vaccine: By 2022, Cambridge-based company to send Switzerland 7 million doses that offer more protection against variants
Updated 7:43 AM;
Eyeing coronavirus variants that are causing global concern, Moderna announced an agreement Thursday with the Swiss government to provide the country in the next year 7 million doses of the Cambridge-based company’s COVID-19 booster vaccine, which has shown to offer more protection against strains of the virus.
The agreement between the biotechnology company and the Swiss Federal Government for 7 million doses of the booster vaccine by next year includes an option for another 7 million shots for delivery during the second half of 2022 or first quarter of 2023, according to a statement from Moderna.
Share:
New Switzerland agreement and option is in additional to earlier agreements for 13.5 million doses
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a new supply agreement with the Swiss Federal Government for 7 million doses of booster vaccine in 2022, with an additional option for another 7 million doses for delivery during the second half of 2022 or first quarter of 2023. Purchase under this agreement is subject to regulatory approval of the booster vaccine candidate. Today s announcement follows two earlier agreements between Switzerland and Moderna to supply a total of 13.5 million doses of the COVID-19 Vaccine Moderna. Swissmedic, the Swiss Agency for Therapeutic Products, authorized the COVID-19 Vaccine Moderna in Switzerland on January 12, 2021.
New proposals announced by the Swiss government
With the intention of making Switzerland more attractive as an international centre for finance and securities trading, the Swiss Federal Government proposes to abolish withholding tax on interest payments on Swiss bonds and also the securities transfer tax on trading in Swiss bonds and certain other debt instruments. At its meeting on April 14 2021 the government issued the formal dispatch in relation to these intended changes.
Switzerland currently levies withholding tax of 35% on interest on bonds issued in Switzerland and bonds issued abroad but reclassified as Swiss bonds. The respective withholding tax may be fully or partially reclaimed where a double taxation treaty applies.